News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
329,704 Results
Type
Article (18872)
Company Profile (109)
Press Release (310723)
Section
Business (89089)
Career Advice (1316)
Deals (17478)
Drug Delivery (59)
Drug Development (61141)
Employer Resources (60)
FDA (9066)
Job Trends (7479)
News (174089)
Policy (15208)
Tag
Academia (1199)
Alliances (17708)
Alzheimer's disease (860)
Approvals (9059)
Artificial intelligence (82)
Bankruptcy (137)
Best Places to Work (6346)
Biotechnology (69)
Breast cancer (190)
Cancer (1197)
Cardiovascular disease (89)
Career advice (1032)
CAR-T (64)
Cell therapy (188)
Clinical research (50518)
Collaboration (302)
Compensation (128)
COVID-19 (2174)
Data (1243)
Diabetes (171)
Diagnostics (3263)
Earnings (52165)
Events (52459)
Executive appointments (168)
FDA (9608)
Funding (307)
Gene therapy (125)
GLP-1 (579)
Government (2370)
Healthcare (9636)
Infectious disease (2222)
Inflammatory bowel disease (75)
Interviews (241)
IPO (10105)
Job creations (1449)
Job search strategy (905)
Layoffs (206)
Legal (2457)
Lung cancer (185)
Lymphoma (85)
Manufacturing (107)
Medical device (6301)
Medtech (6301)
Mergers & acquisitions (7570)
Metabolic disorders (442)
Neuroscience (1121)
NextGen: Class of 2025 (2658)
Non-profit (1841)
Northern California (1194)
Obesity (261)
Opinion (89)
Parkinson's disease (80)
People (15331)
Phase I (14300)
Phase II (24944)
Phase III (16240)
Pipeline (538)
Postmarket research (1585)
Preclinical (4744)
Radiopharmaceuticals (146)
Rare diseases (188)
Real estate (1732)
Regulatory (11446)
Research institute (1158)
Resumes & cover letters (257)
Southern California (1054)
Startups (1335)
United States (9825)
Vaccines (424)
Weight loss (189)
Date
Today (91)
Last 7 days (255)
Last 30 days (1213)
Last 365 days (21938)
2025 (1078)
2024 (22038)
2023 (24446)
2022 (29984)
2021 (32062)
2020 (30536)
2019 (22703)
2018 (17293)
2017 (17516)
2016 (15308)
2015 (18682)
2014 (13373)
2013 (9816)
2012 (10616)
2011 (11095)
2010 (9732)
Location
Africa (406)
Asia (21442)
Australia (3849)
California (2663)
Canada (957)
China (261)
Colorado (98)
Connecticut (130)
Delaware (70)
Europe (47573)
Florida (325)
Georgia (104)
Illinois (171)
Indiana (146)
Japan (77)
Maryland (386)
Massachusetts (1991)
Michigan (80)
Minnesota (147)
New Jersey (781)
New York (786)
North Carolina (382)
Northern California (1194)
Ohio (76)
Pennsylvania (590)
South America (567)
Southern California (1054)
Texas (385)
Utah (69)
Washington State (251)
329,704 Results for "2".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Colorado’s Life Sciences Ecosystem Raised $2.15 Billion in 2024
Fundraising Exceeds $2B for the Second Time in Four-Year Period
December 19, 2024
·
1 min read
Legal
GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines
The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the product liability cases regarding allegations that GSK’s heartburn drug could cause cancer. Analysts say separate concerns remain about its vaccines business.
October 10, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Medexus Announces Strong Fiscal Q2 2025 Results
Fiscal Q2 2025 revenue of $26.3 million, net income of $0.1 million, operating income of $1.6 million, and Adjusted EBITDA* of $6.0 million Management to host conference call at 8:00 AM Eastern time on Friday, November 8, 2024
November 7, 2024
·
23 min read
Press Releases
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
December 18, 2024
·
5 min read
Press Releases
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
December 31, 2024
·
6 min read
Press Releases
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease
December 6, 2024
·
6 min read
Press Releases
NervGen Completes Enrollment in Chronic Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
Topline data from the chronic cohort is expected in Q2 2025 Institutional Review Board (IRB) protocol amendment changes approved, and screening has been initiated for subacute cohortThis news release constitutes a “designated news release” for the purposes of NervGen’s prospectus supplement dated December 19, 2024 to its short form base shelf prospectus dated November 25, 2024.
January 2, 2025
·
7 min read
Press Releases
Genflow Biosciences PLC Announces Holding(s) in Company - 2
January 13, 2025
·
2 min read
Drug Development
IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer
IMUNON, Inc. announces database lock for its Phase 2 OVATION 2 Study evaluating the safety and efficacy of IMNN-001 in patients with advanced ovarian cancer.
June 24, 2024
·
6 min read
Reveal Genomics® HER2DX® Genomic Test Demonstrates Significant Potential in HER2-Positive Advanced Gastric Cancer
Reveal Genomics ® HER2DX ® Genomic Test Demonstrates Significant Potential in HER2-Positive Advanced Gastric Cancer.
June 27, 2024
·
5 min read
1 of 32,971
Next
